AAOI
Applied Optoelectronics, Inc.
AAOI has the edge over CLBT overall, supported by stronger modeled upside.
CLBT
Cellebrite DI Ltd.
CLBT has lower modeled downside risk, despite its lower overall score.
AAOI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
AAOI's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CLBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CLBT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
AAOI PE Valuation
AAOI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
CLBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $1.64 | -85% |
| Forward | 33x | $10.89 | — |
| Fair | 44x | $10.10 | -7.3% |
| Current | 47x | $10.89 | — |
| Expensive | 62x | $14.35 | +32% |
Historical ranges are pointers, not guarantees.
CLBT's PE is in its fair range at 47x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
AAOI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
AAOI has the edge over CLBT on the outlook, with more favorable profitability expectations.
CLBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CLBT, but weaker profitability.
AAOI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.98 | — |
| Q3 2026 | -$0.42 | +$3.02 |
| Q2 2026 | -$0.77 | +$2.81 |
| Q1 2026 | -$0.65 | +$3.43 |
| Q4 2025 | -$0.64 | +$3.86 |
| Q3 2025 | -$3.44 | -$1.41 |
| Q2 2025 | -$3.58 | -$1.70 |
| Q1 2025 | -$4.08 | -$2.29 |
| Q4 2024 | -$4.50 | -$2.75 |
AAOI is still losing money, but far less than before: $0.42 per share over the past year, against $4.50 at its worst in late 2024.
CLBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +46% |
| Q2 2026 | $0.23 | +$0.99 |
| Q1 2026 | $0.29 | +$1.25 |
| Q4 2025 | $0.31 | +$1.70 |
| Q3 2025 | $0.31 | +$1.86 |
| Q2 2025 | -$0.76 | -$0.24 |
| Q1 2025 | -$0.96 | -$0.39 |
| Q4 2024 | -$1.39 | -$0.96 |
| Q3 2024 | -$1.55 | -$1.23 |
CLBT has the edge over AAOI on earnings quality, reporting a profit while its opponent remains loss making.
AAOI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $269.9M | +127% |
| Q2 2026 | $191.9M | +86% |
| Q1 2026 | $151.1M | +51% |
| Q4 2025 | $134.3M | +34% |
| Q3 2025 | $118.6M | +82% |
| Q2 2025 | $103M | +138% |
| Q1 2025 | $99.9M | +146% |
| Q4 2024 | $100.3M | +66% |
AAOI has the edge over CLBT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -0.5% | +15 points |
| Q2 2026 | -13% | +2.6 points |
| Q1 2026 | -8.6% | +0.3 points |
| Q4 2025 | -8.6% | -2.1 points |
| Q3 2025 | -15% | +10 points |
| Q2 2025 | -16% | +45 points |
| Q1 2025 | -8.9% | +44 points |
| Q4 2024 | -6.5% | +1 points |
AAOI's operating margin was −0.5% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
CLBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $131.1M | +16% |
| Q1 2026 | $128.3M | +19% |
| Q4 2025 | $128.8M | +18% |
| Q3 2025 | $126M | +18% |
| Q2 2025 | $113.3M | +18% |
| Q1 2025 | $107.5M | +20% |
| Q4 2024 | $109M | +17% |
| Q3 2024 | $106.9M | +27% |
CLBT's revenue has grown year over year every quarter since early 2021: $131M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.8% | -6.9 points |
| Q1 2026 | 7.1% | -4.3 points |
| Q4 2025 | 16% | +1.7 points |
| Q3 2025 | 15% | -3.1 points |
| Q2 2025 | 13% | -0.3 points |
| Q1 2025 | 11% | +1.1 points |
| Q4 2024 | 14% | -1.7 points |
| Q3 2024 | 18% | +2.2 points |
CLBT has the edge over AAOI on profitability, with a higher operating margin.
AAOI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$369.9M | -$291.2M |
| Q2 2026 | -$265.3M | -$174.4M |
| Q1 2026 | -$143.6M | -$64.3M |
| Q4 2025 | -$104.6M | -$51.6M |
| Q3 2025 | -$78.7M | -$58M |
| Q2 2025 | -$91M | -$86M |
| Q1 2025 | -$79.3M | -$45.1M |
| Q4 2024 | -$53M | -$48.4M |
AAOI has burned cash in almost every quarter: −$883M over the past year, against −$302M the year before.
CLBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $14.5M | -50% |
| Q1 2026 | $16.8M | -9.1% |
| Q4 2025 | $78.3M | +27% |
| Q3 2025 | $30M | -25% |
| Q2 2025 | $29M | +138% |
| Q1 2025 | $18.5M | +134% |
| Q4 2024 | $61.7M | +59% |
| Q3 2024 | $39.8M | +42% |
CLBT has the edge over AAOI on cash generation, producing positive trailing cash flow while its opponent burns cash.
AAOI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.7% | +6.3M shares |
| 1 year | +39% | +24.5M shares |
| 3 years | +168% | +55.1M shares |
| 5 years | +224% | +60.7M shares |
| Available history | +340% | +67.9M shares |
AAOI has 88M diluted shares, up 39% from a year ago.
CLBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +711K shares |
| 1 year | +1.5% | +3.8M shares |
| 3 years | +34% | +64.7M shares |
| 5 years | +35% | +65.6M shares |
| Available history | +35% | +65.6M shares |
CLBT has the edge over AAOI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $11,000 |
CLBT hasn't bought back shares in the past year.
AAOI Net Leverage
AAOI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
| Q2 2023 | -0.6x | Net Cash |
| Q1 2023 | -0.4x | Net Cash |
| Q4 2022 | -0.3x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
CLBT has more cash than debt.
AAOI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.1 | Neutral |
| Stochastic | 4.8 | Oversold |
AAOI's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
CLBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 32.9 | Neutral |
CLBT's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
AAOI PE vs Technology Sector
AAOI has no meaningful PE right now: it lost money over the past year.
CLBT PE vs Technology Sector
| Metric | CLBT | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 67% above |
| PE % | 55 | 39 | 16 pts above |
CLBT is trading at 47x earnings, a 67% premium to the Technology sector's median of 28x, though its recent earnings include one-off gains.
AAOI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.2 | 34% below |
| 20 week MA | $100.6 | 47% below |
| 50 week MA | $100.3 | 47% below |
| 100 week MA | $62.3 | 15% below |
| 200 week MA | $36.9 | 43% above |
AAOI has the edge over CLBT on trend strength, trading above more of its moving averages.
CLBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 5.1% below |
| 20 week MA | $12.6 | 14% below |
| 50 week MA | $13.9 | 22% below |
| 100 week MA | $16.1 | 32% below |
| 200 week MA | $13.1 | 17% below |
CLBT is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
AAOI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.5 | $8.77 | -24% |
| 2021 | $8.77 | $5.64 | -36% |
| 2022 | $5.64 | $1.95 | -65% |
| 2023 | $1.95 | $19.3 | +891% |
| 2024 | $19.3 | $37.7 | +95% |
| 2025 | $37.7 | $37.2 | -1.5% |
| 2026 YTD | $37.2 | $52.9 | +42% |
AAOI has the edge over CLBT on returns for 2026, with the stronger performance.
CLBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.66 | $10.5 | +8.8% |
| 2021 | $10.5 | $8.10 | -23% |
| 2022 | $8.10 | $4.18 | -48% |
| 2023 | $4.18 | $8.66 | +107% |
| 2024 | $8.66 | $22.2 | +156% |
| 2025 | $22.2 | $18.4 | -17% |
| 2026 YTD | $18.4 | $10.9 | -41% |
CLBT's yearly returns have swung widely, from +156% in 2024 to −48% in 2022. It's down 41% so far in 2026.